Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06545669 · ClinicalTrials.gov registry record · Phase 4

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

A Phase 4 study of Tobacco Dependence, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target
1
Study location

NCT06545669: Completed Phase 4 study of Tobacco Dependence, sponsored by Johns Hopkins University.

NCT06545669 is a Phase 4 study of Tobacco Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants, below the 478-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06545669, a Phase 4 study of Tobacco Dependence, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

In low-income housing units in Baltimore, the investigators propose to conduct a pilot two-arm hybrid type 1 effectiveness-implementation RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from public housing units (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. At the 3-month time point, the investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.

Primary Outcome

Acceptability and Feasibility will be assessed through quantitative and qualitative data on factors including (e.g., number of participant engagement, number of barriers,completion of modules, number of sessions with CHW).

Conditions Studied

Interventions

  • OTHER Community Health Worker
  • DRUG Nicotine Replacement Product
  • BEHAVIORAL C-Raven Virtual Tobacco Cessation Counseling
  • OTHER Lung Cancer Screening

Study Locations (1)

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-10-30
Est. Completion 2026-01-16
Phase Phase 4
Johns Hopkins University

1,448 total trials

What the finished NCT06545669 record still lists

NCT06545669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 478-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 4 interventions - of which Community Health Worker is the first listed.

NCT06545669 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06545669 about?

NCT06545669 is a clinical study titled "C-Raven, a Virtual Tobacco Cessation Intervention in the Community". In low-income housing units in Baltimore, the investigators propose to conduct a pilot two-arm hybrid type 1 effectiveness-implementation RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b)...

What is the current status of trial NCT06545669?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2024-10-30. Estimated completion is 2026-01-16.

What conditions does trial NCT06545669 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT06545669?

The interventions under investigation include: Community Health Worker (OTHER), Nicotine Replacement Product (DRUG), C-Raven Virtual Tobacco Cessation Counseling (BEHAVIORAL), Lung Cancer Screening (OTHER).

Who is sponsoring clinical trial NCT06545669?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06545669 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06545669's enrollment target sits among peer trials

10 29th of 28 the lowest of 28 other Tobacco Dependence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06545669, the US trial registry maintained by the National Library of Medicine. NCT06545669 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.